OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Creator
-
Jacobs, B.
- Contributor
-
Kibler, K.
Wong, S.
Huynh, T.
Holechek, S.
Denzler, K.
Arndt, W.
Parrington, M.
Tartaglia, J.
Pantaleo, G.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-O13
- URN
-
urn:nbn:de:1111-2016080710212
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jacobs, B.
- Kibler, K.
- Wong, S.
- Huynh, T.
- Holechek, S.
- Denzler, K.
- Arndt, W.
- Parrington, M.
- Tartaglia, J.
- Pantaleo, G.
- SpringerLink (Online service)
Other Objects (12)
Development of replication-competent adenovirus based vaccine vectors
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
Do humans have replication-competent endogenous retroviruses?
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro
Evaluation of a replication-competent VSV-SIV vaccine candidate
Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
Replication competent HIV-guided CRISPR screen identifies novel antiviral factors
Development of replication-competent adenovirus based vaccine vectors
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
Do humans have replication-competent endogenous retroviruses?
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro
Evaluation of a replication-competent VSV-SIV vaccine candidate
Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions
Replication competent HIV-guided CRISPR screen identifies novel antiviral factors
Development of replication-competent adenovirus based vaccine vectors
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
Do humans have replication-competent endogenous retroviruses?
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
P17-23. Enhanced expression of HIV antigens and improved antigen presentation after infection with replication competent attenuated vaccinia virus in vitro
Evaluation of a replication-competent VSV-SIV vaccine candidate
Viral Live‐Attenuated Vaccines (LAVs): Past and Future Directions